Share purchase plan Completed
Prescient Therapeutics share purchase plan
Announced 26 Aug 2026 · ASX: PTX
Advisers
Prescient Therapeutics
Issuer
Not disclosed
Lead managers
- Lead manager
- Issuer
- Prescient Therapeutics
- Completed
- 30 Sep 2026
- Amount raised
- A$7m
- Sector
- Biotech and pharmaceuticals
Similar deals
- Neurizon Therapeutics placement Nov 2026 · A$4.3m · Biotech and pharmaceuticals
- Invex Therapeutics placement Oct 2026 · A$10m · Biotech and pharmaceuticals
- Identifai Genetics IPO Oct 2026 · A$10m · Biotech and pharmaceuticals
- Cynata Therapeutics entitlement offer Oct 2026 · A$912,962 · Biotech and pharmaceuticals
- Nyrada placement Sep 2026 · A$14m · Biotech and pharmaceuticals
Sources
- 26 Aug 2026 Prescient Therapeutics Opens SPP to Raise $7m Today ASX
- 30 Sep 2026 Application for quotation of securities - PTX ASX